IMMvention Therapeutix
Rtp, US · Founded 2017 · Delaware corporation · 1 known investors
Founders & leadership
MC
Matthew CohenNamed on SEC filing
AG
Anil GoyalNamed on SEC filing
LO
Lev OsherovichNamed on SEC filing
JT
Jenny TingNamed on SEC filing
MV
Mark VellacaNamed on SEC filing
Board
BS
Benjamin ScruggsBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$8.9M disclosed across 2 rounds · 2020–2022
▶$2MraisedJan 2023 · 4 investors · BiotechnologyRule 506(b)
▶$2MraisedJan 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jenny TingDirector
- Marilyn ThompsonExecutive Officer
- Mark VellecaDirector
- Anil GoyalExecutive Officer, Director
- Lev OsherovichDirector
- Benjamin ScruggsDirector
- Matthew CohenDirector
- Offering amount
- $4M
- Amount sold
- $2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedNov 2021 · 5 investors · BiotechnologyRule 506(b)
▶$6.9MraisedNov 2021 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew CohenDirector
- Anil GoyalExecutive Officer, Director
- Lev OsherovichDirector
- Jenny TingDirector
- Benjamin ScruggsDirector
- Mark VellacaDirector
- Offering amount
- $6.9M
- Amount sold
- $6.9M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are IMMvention Therapeutix's investors?
- IMMvention Therapeutix's investors include Hatteras Venture Partners.
- How much funding has IMMvention Therapeutix raised?
- IMMvention Therapeutix has disclosed $8.9M raised across 2 rounds.
- Where is IMMvention Therapeutix headquartered?
- IMMvention Therapeutix is headquartered in Rtp, US.